Table 1.
Trait | Terminology 1 | N | Mean ± SE 2 | Genetic variance | Residual variance | Total variance | h2 ± SE |
---|---|---|---|---|---|---|---|
IMF (%) |
Intramuscular fat |
382 |
2.77 ± 0.05 |
0.196 |
0.490 |
0.686 |
0.29 ± 0.16 |
C12:0 (mg/mg) |
Lauric acid |
374 |
0.07 ± 0.001 |
0.000039 |
0.00072 |
0.000761 |
0.05 ± 0.09 |
C14:0 |
Myristic acid |
378 |
3.54 ± 0.03 |
0.0530 |
0.250 |
0.303 |
0.17 ± 0.11 |
C14:1 cis-9 |
Myristoleic acid |
378 |
0.96 ± 0.01 |
0.0076 |
0.041 |
0.0486 |
0.16 ± 0.11 |
C15:0 |
Pentadecylic acid |
378 |
0.80 ± 0.02 |
0.0 |
0.052 |
0.052 |
0 ± 0.06 |
C16:0 |
Palmitic acid |
378 |
26.69 ± 0.15 |
0.6070 |
7.068 |
7.675 |
0.08 ± 0.10 |
C16:1 cis-9 |
Palmitoleic acid |
378 |
3.31 ± 0.04 |
0.0640 |
0.354 |
0.418 |
0.15 ± 0.10 |
C17:0 |
Margaric acid |
378 |
1.07 ± 0.009 |
0.0061 |
0.019 |
0.0251 |
0.24 ± 0.15 |
C17:1 |
Heptadecenoic acid |
378 |
0.58 ± 0.007 |
0.0024 |
0.009 |
0.0114 |
0.20 ± 0.12 |
C18:0 |
Stearic acid |
378 |
14.98 ± 0.14 |
1.3380 |
5.348 |
6.686 |
0.20 ± 0.12 |
C18:1 cis-9 |
Oleic acid |
378 |
37.46 ± 0.22 |
2.0720 |
10.826 |
12.898 |
0.16 ± 0.11 |
C18:1 cis-11 |
Cis-Vaccenic acid |
378 |
2.98 ± 0.05 |
0.0850 |
0.357 |
0.442 |
0.02 ± 0.09 |
C18:1 cis-12 |
Cis-12 Octadecenoic |
377 |
0.91 ± 0.02 |
0.0030 |
0.034 |
0.037 |
0.09 ± 0.10 |
C18:1, cis-13 |
Cis-13 Octadecenoic |
377 |
0.58 ± 0.008 |
0.0 |
0.021 |
0.021 |
0 ± 0.06 |
C18:1 cis-15 |
Cis-15 Octadecenoic |
377 |
0.06 ± 0.002 |
0.0 |
0.0005 |
0.0005 |
0 ± 0.06 |
C18:1 trans-6, 7, 8 |
Trans-6,7,8 Octadecenoic |
378 |
0.18 ± 0.004 |
0.0007 |
0.0055 |
0.0062 |
0.11 ± 0.09 |
C18:1 trans-10, 11, 12 |
Trans-10,11,12 Octadecenoic |
378 |
1.07 ± 0.02 |
0.0236 |
0.0926 |
0.1162 |
0.20 ± 0.12 |
C18:1 trans-16 |
Trans-16 Octadecenoic |
377 |
0.14 ± 0.003 |
0.0 |
0.0023 |
0.0023 |
0 ± 0.09 |
C18:2 cis-9 cis-12 n-6 |
Linoleic acid |
377 |
1.60 ± 0.03 |
0.0340 |
0.239 |
0.273 |
0.12 ± 0.10 |
C18:2 cis-9 trans-11 |
Vaccenic acid |
377 |
0.21 ± 0.003 |
0.0001 |
0.0026 |
0.0027 |
0.04 ± 0.09 |
C18:2 trans-11 cis-15 |
Octadecenoic acid |
374 |
0.07 ± 0.001 |
0.00007 |
0.0004 |
0.00047 |
0.13 ± 0.11 |
C18:3 n-6 |
α-Linolenic acid |
377 |
0.06 ± 0.001 |
0.00008 |
0.0002 |
0.00028 |
0.24 ± 0.13 |
C18:3 n-3 |
γ-Linolenic acid |
376 |
0.16 ± 0.005 |
0.00026 |
0.0017 |
0.00196 |
0.13 ± 0.11 |
C20:1 |
Eicosanoic acid |
374 |
0.11 ± 0.002 |
0.00013 |
0.0014 |
0.00153 |
0.09 ± 0.10 |
C20:2 |
Eicosadienoic acid |
306 |
0.01 ± 0.0003 |
0.0 |
0.00004 |
0.00004 |
0 ± 0.08 |
C20:3 n-6 |
Eicosatrienoic acid |
373 |
0.11 ± 0.003 |
0.00018 |
0.00235 |
0.00253 |
0.07 ± 0.09 |
C20:4 n-6 |
Arachidonic acid |
377 |
0.36 ± 0.008 |
0.00221 |
0.0235 |
0.0251 |
0.09 ± 0.10 |
C20:5 n-3 (EPA) |
Eicosapentaenoic acid |
376 |
0.08 ± 0.002 |
0.00005 |
0.00135 |
0.00139 |
0.04 ± 0.09 |
C22:5 n-3 (DPA) |
Docosapentaenoic acid |
377 |
0.17 ± 0.003 |
0.00047 |
0.00387 |
0.00434 |
0.11 ± 0.10 |
C22:6 n-3 (DHA) |
Docosahexaenoic acid |
364 |
0.03 ± 0.001 |
0.00003 |
0.00018 |
0.00021 |
0.13 ± 0.10 |
SFA3 |
Sum of saturated FA |
377 |
47.23 ± 0.23 |
1.960 |
15.00 |
16.960 |
0.11 ± 0.09 |
MUFA3 |
Sum of monounsaturated FA |
377 |
48.34 ± 0.23 |
2.367 |
14.963 |
17.33 |
0.14 ± 0.10 |
PUFA3 |
Sum of polyunsaturated FA |
377 |
2.87 ± 0.04 |
0.097 |
0.547 |
0.644 |
0.15 ± 0.10 |
n-34 |
Sum of omega-3 |
377 |
0.44 ± 0.09 |
0.00034 |
0.0016 |
0.00194 |
0.17 ± 0.11 |
n-64 |
Sum of omega-6 |
377 |
2.13 ± 0.04 |
0.00055 |
0.0031 |
0.00365 |
0.15 ± 0.11 |
PUFA:SFA |
Ratio of PUFA to SFA |
377 |
6.08 ± 0.003 |
0.0623 |
0.41 |
0.4723 |
0.13 ± 0.10 |
n-6:n-3 |
Ratio of n-6 to n-3 |
377 |
4.84 ± 0.11 |
0.00395 |
0.0231 |
0.02705 |
0.14 ± 0.10 |
AI5 | Atherogenic index | 377 | 0.82 ± 0.05 | 0.03943 | 1.0784 | 1.11783 | 0.03 ± 0.09 |
1IUPAC Compendium of Chemical Terminology.
2SE Standard error.
3MUFA, PUFA and SFA were the total of all monounsaturated, polyunsaturated and saturated fatty acids, respectively.
4n-3 and n-6 were total of omega 3 and 6 fatty acids.
5Atherogenic index = [12:0 + 4(14:0) + 16:0]/(SFA + PUFA).